![Joseph Palumbo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Palumbo
Technik-/Wissenschafts-/F&E-Leiter bei
BIOVIE INC.
Vermögen: 1 552 $ am 31.05.2026
Profil
Joseph M.
Palumbo currently serves as Chief Medical Officer, EVP-Research & Development at BioVie, Inc. since 2021 and as Chief Medical Officer at Option Therapeutics, Inc. Formerly, Dr. Palumbo was Chief Medical Officer & Vice President at Zynerba Pharmaceuticals, Inc. from 2019 to 2021, Vice President-US Medical Science at Tanabe Pharma Corp., and Head-Global & Franchise Medical at Johnson & Johnson.
Education includes undergraduate studies at the University of Pennsylvania Graduate School of Education and a doctorate from George Washington University School of Medicine & Health.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOVIE INC. CLASS A 0,01 % | 05.01.2026 | 1 093 ( 0,01 % ) | 1 552 $ | 31.05.2026 |
Aktive Positionen von Joseph Palumbo
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOVIE INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2021 |
Ehemalige bekannte Positionen von Joseph Palumbo
| Unternehmen | Position | Ende |
|---|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2021 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
| MITSUBISHI TANABE PHARMA CORPORATION | Corporate Officer/Principal | - |
Ausbildung von Joseph Palumbo
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Zynerba Pharmaceuticals, Inc.
 Zynerba Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Delivers dermal solutions for the treatment of neuroscience disorders | Health Technology |
BioVie, Inc.
 BioVie, Inc. BiotechnologyHealth Technology Develops drug therapies for chronic debilitating conditions | Health Technology |
Mitsubishi Tanabe Pharma Corp.
 Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
University of Pennsylvania Graduate School of Education
 University of Pennsylvania Graduate School of Education Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
George Washington University School of Medicine & Health
 George Washington University School of Medicine & Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wählen Sie MarketScreener 
